Why the form of vitamin B12 you take may matter more than your intake
View as a Web Page
News Medical
 
  Gastroenterology Gastroenterology logo  
  The latest gastroenterology‎ news from News Medical  
 Industrial and farm chemicals quietly alter the balance of gut microbesIndustrial and farm chemicals quietly alter the balance of gut microbes
 
This study systematically screened over 1,000 agricultural and industrial chemicals and found that many can inhibit human gut bacteria in vitro. Beyond antimicrobial effects, these chemicals act as selective pressures that can reshape microbial competition, tolerance mechanisms, and metabolic pathways.
 
 
 Why the form of vitamin B12 you take may matter more than your intakeWhy the form of vitamin B12 you take may matter more than your intake
 
This comprehensive review examines vitamin B12 absorption, physiological roles, deficiency states, and dietary sources, with particular attention to differences between natural and synthetic forms. The authors conclude that while all B12 forms raise circulating levels, methylcobalamin may offer advantages in specific clinical contexts, especially where absorption or metabolic conversion is impaired.
 
   Settling the creatine safety debateSettling the creatine safety debate
 
Research confirms creatine's safety, highlighting misinformation and low-quality supplements as primary concerns over cancer and kidney health risks.
 
   Gut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switchGut microbe metabolite TMA improves blood sugar by shutting down a key inflammatory switch
 
Researchers identified trimethylamine (TMA) as a gut microbe–derived metabolite that directly inhibits IRAK4 to reduce metabolic inflammation and improve glycaemic control in high-fat-diet-fed mice. Choline-driven increases in TMA production replicated these benefits, revealing a host–microbe signaling axis with therapeutic potential for obesity-associated insulin resistance.
 
   How ultra-processed foods shape Crohn’s disease risk and what dietary strategies can really helpHow ultra-processed foods shape Crohn’s disease risk and what dietary strategies can really help
 
This narrative review synthesizes evidence showing that higher intake of ultra-processed foods is consistently associated with increased Crohn’s disease risk, with mechanistic pathways implicating emulsifiers, carrageenan, maltodextrin, titanium dioxide, sweeteners and salt. It also highlights that minimally processed dietary strategies, including EEN and CDED, show therapeutic promise, particularly in pediatric Crohn’s disease.
 
 Study provides new hope for future treatment of intestinal condition IBS
 
Researchers at örebro University in Sweden have made a significant advance in understanding the intestinal condition IBS.
 
 
 Sterilized fermented beverage targets obesity and type 2 diabetes pathways in computational study
 
Sterilized fermented beverage targets obesity and type 2 diabetes pathways in computational studyResearchers profiled a terminally sterilized probiotic-fermented MFH beverage and identified aporphine alkaloids and flavonoids with favorable predicted ADMET properties. Integrated network pharmacology, molecular docking, and 100-ns MD simulations suggest multi-target engagement of metabolic-inflammatory pathways relevant to obesity and type 2 diabetes.
 
 
 Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root cause
 
Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root causeSerious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, are associated with high rates of death unrelated to cancer relapse-primarily infection-and may be avoidable.
 
 
 New findings show why the human intestine uniquely presents gluten to T cells
 
New findings show why the human intestine uniquely presents gluten to T cellsHuman intestinal M cells function as dendritic cell-like antigen-presenting cells, displaying constitutive MHC-II activity and specialized machinery for processing gluten. Their ability to deamidate and present gliadin peptides positions them as key initiators of immune responses relevant to coeliac disease.
 
 
 Lubiprostone shows signs of slowing kidney function decline in chronic kidney disease
 
Lubiprostone shows signs of slowing kidney function decline in chronic kidney diseaseIn adults with stage IIIb–IV chronic kidney disease, the constipation drug lubiprostone did not reduce gut-derived uremic toxins but preserved creatinine-based kidney function over 24 weeks. The benefit was linked to microbiome remodeling, increased polyamine production, and improved mitochondrial function rather than toxin lowering.
 
 
 Pneumococcal vaccination lowers antibiotic-resistant bacteria in children
 
Pneumococcal vaccination lowers antibiotic-resistant bacteria in childrenChildren in Guatemala who received a common vaccine that helps prevent pneumonia were less likely to carry antibiotic-resistant bacteria, according to a new study led by Washington State University researchers.
 
 
 Low-cost pantoprazole improves outcomes, reduces ICU stay, study finds
 
Low-cost pantoprazole improves outcomes, reduces ICU stay, study findsA study led by McMaster University researchers shows that a widely available and inexpensive medication not only prevents potentially serious stomach bleeding in critically ill patients, but also saves hospitals thousands of dollars.
 
 
 Mass General Brigham launches AI company to enhance clinical trial matching
 
Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly outperformed manual screening for determining a patient's eligibility and enrolling them in a clinical trial.
 
 
 Why soybean oil may fuel weight gain
 
Why soybean oil may fuel weight gainResearchers investigate how soybean oil may disrupt fat metabolism to potentially increase the risk of obesity.
 
 
 Asian IBD patients show lower PSC prevalence and better clinical outcomes
 
Asian IBD patients show lower PSC prevalence and better clinical outcomesPrimary sclerosing cholangitis (PSC) is a chronic, progressive inflammatory disease characterized by fibrosis and bile duct stricturing, which ultimately leads to cirrhosis and liver failure. PSC is strongly associated with both types of inflammatory bowel disease (IBD), namely, ulcerative colitis and Crohn's disease.
 
 
 Discovery links human M cells to early steps of celiac disease
 
Discovery links human M cells to early steps of celiac diseaseThe human small intestine absorbs nutrients while protecting us from potentially harmful microbes. One of the cell types that plays a key role in this protection is the microfold cell, or M cell.
 
 
 Over-contracted gut muscles drive gastrointestinal symptoms in myotonic dystrophy
 
Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people. While it is well known for causing muscle weakness and stiffness, DM1 also affects other organs, including the brain, heart and gastrointestinal (GI) tract.
 
 
 Study reveals how Ebola and Marburg viruses damage the human gut
 
Study reveals how Ebola and Marburg viruses damage the human gutEbola (EBOV) and Marburg virus (MARV) are highly lethal viruses that cause severe disease in infected patients by extensively damaging the body.
 
 
 Understanding how adult brains adapt to challenge and change
 
Understanding how adult brains adapt to challenge and changeIn a revelatory Genomic Press Interview published today in Brain Medicine, Dr. Paul Lucassen, full professor at the University of Amsterdam and leader of the Brain Plasticity group, shares his scientific journey that helped transform our understanding of how adult brains adapt to challenge and change.
 
 
 Study uncovers how the body's bile acids bind to block C. diff's most dangerous toxin
 
Study uncovers how the body's bile acids bind to block C. diff's most dangerous toxinIn a major step towards a precision therapy for Clostridioides difficile (C. diff) infection, researchers at The Hospital for Sick Children (SickKids) have uncovered how the body's bile acids bind to block C. diff's most dangerous toxin.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025